ClarisHealth

Name: ClarisHealth
Brand: ClarisHealth

Get Expert Technology to Drive Claims Payment Accuracy with Pareo®

Est 2013|Valuation $180M|Raised $57.5M|4 Ref Customers

LinkedIn 38K|Website|FTEs 136|HQ Franklin, Tennessee, US

Published Oct 14, 2026

01Common complaints

1. Organizations that require transparent, self-serve pricing and quick SMB onboarding. ClarisHealth operates an enterprise-led sales model with no public pricing. 2. Organizations that require extensive independent customer reviews and public referenceability prior to procurement; vendor presence on mainstream review platforms is limited. 3. Organizations seeking a single incumbent to own PI services end-to-end with large-scale provider outreach and collections; larger incumbents may provide more integrated service capabilities. 4. Organizations with low tolerance for execution risk (for example, where delivery capacity, turnover, or overpromising would be unacceptable). In such cases, prioritize vendors with mature delivery organizations and extensive referenceability. 5. Organizations that only require narrow point capabilities (for example, a specific prepay editing engine or a specialized fraud detection tool); a targeted point solution may be faster and less expensive.

Disqualifiers (poor fit)

Very small plans with low PI complexity where platform overhead may outweigh benefits.
Organizations seeking a single end-to-end services outsourcing partner to handle all PI activities (rather than a governance/orchestration platform).
Organizations unable or unwilling to invest in integration and change management.

Publicly acknowledged limitations

The vendor does not provide a public list of known product issues comparable to developer-tool issue trackers.

Practical limitations inferred from sources

Pricing opacity: requires an enterprise sales engagement to obtain cost information.
Limited public third-party review footprint: reduces public transparency about typical deployment pitfalls.
Execution risk indicators from employee reviews: allegations of bugs, process churn, and overpromising could translate to variable customer experience.

Roadmap / future features

No specific dated roadmap items were found in reviewed public materials. Buyers should request roadmap details, release cadence, and options for customer advisory participation as part of procurement discussions.

Why customers might leave (inferred risks)

Based on typical PI software adoption patterns and the execution risk indicators above, possible reasons for churn include:

Implementation complexity and slow time-to-value.
Friction arising from workflow and process changes.
Dissatisfaction with support and delivery if staffing or turnover issues affect service quality.
A decision to move to a larger incumbent offering broader PI content and services.

02Why they buy

Claims supported by available evidence (limited)

The vendor emphasizes an integrated platform message spanning pre-pay and post-pay workflows.
HITRUST certification is documented in vendor press materials.
The vendor publishes a named case study with specific client outcomes, which represents stronger vendor-supplied evidence than generic testimonials.

Differentiators claimed by the vendor (require validation)

Vendor describes Pareo as integrating prepay and post-pay payment integrity workflows into a single platform; buyers should validate the scope and functionality versus competitors.
Vendor promotes a partner exchange approach for pre-integrated vendor and partner integrations; buyers should validate integration coverage and actual implementation timelines with references and SOWs.

Where competitors may have advantages

Larger incumbents often provide deeper clinical content libraries, broader professional services capacity, and extensive benchmarking data.

03Field reports

Important limitation: absence of mainstream SaaS review-platform coverage

ClarisHealth/Pareo does not appear to have profiles on platforms such as G2 or Capterra based on the research conducted. This reduces third-party visibility compared with mainstream SaaS offerings. Where third-party reviews are not available, vendor-published testimonials and case studies should be treated as vendor-selected and directional rather than independently verified. This report draws on: - Vendor-published testimonials and case studies. - Employee sentiment from Glassdoor/Indeed as a proxy for execution risk. - Corporate records (BBB) for company context.

Vendor-published testimonials (directional evidence)

The vendor’s website includes multiple user-attributed quotes indicating perceived value around reporting, consolidation of operations, and scaling of programs. Examples presented on the vendor site include statements that Pareo served as a consolidated operational platform for PI and that the platform supported scaling third-party supplier programs. These vendor-selected quotes provide directional signals but are not independent evidence of typical outcomes.

Case study evidence (vendor-produced)

A vendor case study describes a Managed Medicaid plan selecting a vendor service offering; the vendor reports auditors identified material savings in the early months of the engagement. The case study reports the plan was a mid-sized program and provides an engagement timeline. These are vendor-published performance indicators and should be validated during procurement.

Negative signals and execution risk indicators

Because mainstream customer review platforms were not found, the most available negative signals come from employee reviews and informal comments: - Glassdoor shows the company is poorly rated on that platform, indicating mixed employee sentiment. - Individual employee reviews allege culture and management issues, unpaid overtime expectations, high turnover, and instances where sales commitments exceeded delivery capacity. These are unverified individual accounts but represent potential execution and delivery risk factors that buyers should probe with references.

Why customers choose ClarisHealth (inferred)

Common reasons suggested by vendor materials and case studies:

Desire for a single operational platform across PI vendors and internal teams.
Need to insource parts of PI without developing a full internal platform.
To develop pre-pay capabilities and detect payment issues earlier in the claims lifecycle.

Case study: Managed Medicaid plan

- A vendor case study reports a Managed Medicaid plan selected a vendor service offering; the vendor reports auditors identified material recoveries in the initial months of the engagement. The case study describes the plan as a mid-sized program and provides an engagement timeline. Critical evaluation: - Metrics are vendor-published and do not include counterfactual analysis or detail whether reported amounts represent gross identifications, net recoveries, or realized savings net of fees and disputes. - The named client asset (an identifiable plan) and timeline provide a stronger vendor reference than generic testimonials, but buyers should request contract-level details and client references to validate outcomes.

ROI research: Commissioned study

The vendor publicized a commissioned ROI study that reported a multi-fold ROI based on interviews with vendor-selected clients and quantified value categories.

Critical evaluation:

Commissioned studies can provide directional evidence but may rely on client-reported outcomes and vendor-selected samples. Buyers should request the full methodology, sample selection criteria, and normalization approach.

04Best fit

Company size / scale

Best fit appears to be mid-to-large health plans where PI involves multiple vendors and significant audit/inventory volume. Examples include regional and national plans and Medicaid MCOs.

Industries / verticals

Health insurance / managed care (commercial, Medicare Advantage, Medicaid).
Third-party administrators (TPAs).

Personas

VP/Director of Payment Integrity / Claims Integrity.
Payment Integrity Operations leaders.
Vendor management and finance leaders responsible for recoveries and ROI.
IT and data leaders responsible for integrations and analytics governance.

Qualification criteria (good fit)

Organization has multiple PI vendors and requires consolidation of audit inventories, reporting, and workflow orchestration.
Organization seeks to insource parts of PI without building a fully custom platform.
Organization requires better workflow governance across vendor and internal audit activities.

05The pitch

What the product does (objective value proposition)

ClarisHealth is a B2B healthcare technology company focused on payment integrity (PI) for health plans and payers. Its core product, Pareo, is positioned by the vendor as a unified platform to manage pre-pay and post-pay payment integrity workflows, vendor oversight, audit inventory management, analytics, and increasingly, machine-learning-assisted detection and workflow automation. The vendor states the goals are to improve claims payment accuracy, reduce waste, and reduce administrative overhead for managing PI programs across internal teams and third-party vendors. On its website, the vendor describes Pareo as a single platform that unifies PI operations with machine-learning-assisted automation, real-time analytics, and inventory management features, and cites vendor-published scale indicators including multiple health plan clients and large volumes of claims processed. These figures are vendor-published and independent validation is limited.

Target market and positioning

- Primary buyers: U.S. health plans and payers (commercial, Medicaid MCOs, Blues plans, TPAs). - Key use cases: PI program consolidation and modernization; consolidating disparate PI vendors and legacy tooling; supporting strategies to bring parts of PI in-house. - Positioning theme: Vendor presents Pareo as an integrated PI platform spanning pre-pay to post-pay, with visibility and governance over vendors and focused workflow management intended to detect payment issues earlier in the lifecycle (prospective PI).

Get a comprehensive analysis of ClarisHealth including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →

Published Oct 14, 2026

01Common complaints

Organizations that require transparent, self-serve pricing and quick SMB onboarding. ClarisHealth operates an enterprise-led sales model with no public pricing.
Organizations that require extensive independent customer reviews and public referenceability prior to procurement; vendor presence on mainstream review platforms is limited.
Organizations seeking a single incumbent to own PI services end-to-end with large-scale provider outreach and collections; larger incumbents may provide more integrated service capabilities.
Organizations with low tolerance for execution risk (for example, where delivery capacity, turnover, or overpromising would be unacceptable). In such cases, prioritize vendors with mature delivery organizations and extensive referenceability.
Organizations that only require narrow point capabilities (for example, a specific prepay editing engine or a specialized fraud detection tool); a targeted point solution may be faster and less expensive.

Disqualifiers (poor fit)

Very small plans with low PI complexity where platform overhead may outweigh benefits.
Organizations seeking a single end-to-end services outsourcing partner to handle all PI activities (rather than a governance/orchestration platform).
Organizations unable or unwilling to invest in integration and change management.

Publicly acknowledged limitations

The vendor does not provide a public list of known product issues comparable to developer-tool issue trackers.

Practical limitations inferred from sources

Pricing opacity: requires an enterprise sales engagement to obtain cost information.
Limited public third-party review footprint: reduces public transparency about typical deployment pitfalls.
Execution risk indicators from employee reviews: allegations of bugs, process churn, and overpromising could translate to variable customer experience.

Roadmap / future features

Why customers might leave (inferred risks)

Based on typical PI software adoption patterns and the execution risk indicators above, possible reasons for churn include:

Implementation complexity and slow time-to-value.
Friction arising from workflow and process changes.
Dissatisfaction with support and delivery if staffing or turnover issues affect service quality.
A decision to move to a larger incumbent offering broader PI content and services.

02Why they buy

Claims supported by available evidence (limited)

The vendor emphasizes an integrated platform message spanning pre-pay and post-pay workflows.
HITRUST certification is documented in vendor press materials.
The vendor publishes a named case study with specific client outcomes, which represents stronger vendor-supplied evidence than generic testimonials.

Differentiators claimed by the vendor (require validation)

Vendor describes Pareo as integrating prepay and post-pay payment integrity workflows into a single platform; buyers should validate the scope and functionality versus competitors.
Vendor promotes a partner exchange approach for pre-integrated vendor and partner integrations; buyers should validate integration coverage and actual implementation timelines with references and SOWs.

Where competitors may have advantages

Larger incumbents often provide deeper clinical content libraries, broader professional services capacity, and extensive benchmarking data.

03Field reports

Important limitation: absence of mainstream SaaS review-platform coverage

This report draws on:

Vendor-published testimonials and case studies.
Employee sentiment from Glassdoor/Indeed as a proxy for execution risk.
Corporate records (BBB) for company context.

Vendor-published testimonials (directional evidence)

Case study evidence (vendor-produced)

Negative signals and execution risk indicators

Because mainstream customer review platforms were not found, the most available negative signals come from employee reviews and informal comments:

Glassdoor shows the company is poorly rated on that platform, indicating mixed employee sentiment.
Individual employee reviews allege culture and management issues, unpaid overtime expectations, high turnover, and instances where sales commitments exceeded delivery capacity. These are unverified individual accounts but represent potential execution and delivery risk factors that buyers should probe with references.

Why customers choose ClarisHealth (inferred)

Common reasons suggested by vendor materials and case studies:

Desire for a single operational platform across PI vendors and internal teams.
Need to insource parts of PI without developing a full internal platform.
To develop pre-pay capabilities and detect payment issues earlier in the claims lifecycle.

Case study: Managed Medicaid plan

A vendor case study reports a Managed Medicaid plan selected a vendor service offering; the vendor reports auditors identified material recoveries in the initial months of the engagement. The case study describes the plan as a mid-sized program and provides an engagement timeline.

Critical evaluation:

Metrics are vendor-published and do not include counterfactual analysis or detail whether reported amounts represent gross identifications, net recoveries, or realized savings net of fees and disputes.
The named client asset (an identifiable plan) and timeline provide a stronger vendor reference than generic testimonials, but buyers should request contract-level details and client references to validate outcomes.

ROI research: Commissioned study

The vendor publicized a commissioned ROI study that reported a multi-fold ROI based on interviews with vendor-selected clients and quantified value categories.

Critical evaluation:

Commissioned studies can provide directional evidence but may rely on client-reported outcomes and vendor-selected samples. Buyers should request the full methodology, sample selection criteria, and normalization approach.

04Best fit

Company size / scale

Best fit appears to be mid-to-large health plans where PI involves multiple vendors and significant audit/inventory volume. Examples include regional and national plans and Medicaid MCOs.

Industries / verticals

Health insurance / managed care (commercial, Medicare Advantage, Medicaid).
Third-party administrators (TPAs).

Personas

VP/Director of Payment Integrity / Claims Integrity.
Payment Integrity Operations leaders.
Vendor management and finance leaders responsible for recoveries and ROI.
IT and data leaders responsible for integrations and analytics governance.

Qualification criteria (good fit)

Organization has multiple PI vendors and requires consolidation of audit inventories, reporting, and workflow orchestration.
Organization seeks to insource parts of PI without building a fully custom platform.
Organization requires better workflow governance across vendor and internal audit activities.

05The pitch

What the product does (objective value proposition)

On its website, the vendor describes Pareo as a single platform that unifies PI operations with machine-learning-assisted automation, real-time analytics, and inventory management features, and cites vendor-published scale indicators including multiple health plan clients and large volumes of claims processed. These figures are vendor-published and independent validation is limited.

Target market and positioning

Primary buyers: U.S. health plans and payers (commercial, Medicaid MCOs, Blues plans, TPAs).
Key use cases: PI program consolidation and modernization; consolidating disparate PI vendors and legacy tooling; supporting strategies to bring parts of PI in-house.
Positioning theme: Vendor presents Pareo as an integrated PI platform spanning pre-pay to post-pay, with visibility and governance over vendors and focused workflow management intended to detect payment issues earlier in the lifecycle (prospective PI).

Get a comprehensive analysis of ClarisHealth including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →